The Emory University Lab Behind What Could Be a Gamechanging COVID-19 Pill
Monday, October 11th, 2021
Drug company Merck is awaiting word on its emergency use authorization application for its recently announced drug molnupiravir. If approved, the anti-viral drug developed at a lab at Emory University could become the first-ever pill to treat COVID-19. The latest Georgia Today podcast examines the journey that led to this potential breakthrough and its connection to Emory.
Read More at GPB.
